Aki Takimoto

Aki Takimoto

Auto-generated profile, based on publicly available information

Aki Takimoto

Institute for Frontier Medical Sciences, Kyoto University 4 Department of Cellular Differentiation Kyoto 606-8507

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 May 2026 in Development
Verified
Journal Article
Closed access
SYShinsei Yambe
Shinsei Yambe
KSKenta Sumiyama
Kenta Sumiyama
HWHitomi Watanabe
Hitomi Watanabe
ATAki Takimoto
Aki Takimoto
TSTakako Sasaki
Takako Sasaki
CSChisa Shukunami
Chisa Shukunami
Scleraxis (Scx) is a basic helix-loop-helix transcription factor predominantly expressed in tendons, ligaments, and their attachment sites, where it regulates maturation. Here, we report a novel Scx enhancer that drives tissue-specific expression. In transgenic reporter mice, a 5.3 kb downstream Scx enhancer (dSE) conferred robust, stable, and faithful reporter activity reproducing the endogenous Scx expression pattern. Within the dSE, we identified a 343 bp Scx enhancer (CSE), conserved from lobe-finned fishes to tetrapods, that recapitulates Scx expression in limbs. In developing limbs, CSE-deficient mice exhibited a marked reduction of endogenous Scx expression and a complete loss of the deltoid tuberosity (DT) supporting forelimb leverage, accompanied by attenuated BMP and TGFβ signaling, as in Scx-deficient mice. Precise enhancer activation within a particular developmental window was indispensable for DT formation. In contrast, tendon/ligament maturation retained prolonged plasticity, with Scx expression partially recovering later, likely through additional elements within the dSE. These findings uncover an essential role of the CSE in DT morphogenesis and reveal distinct temporal enhancer requirements for DT versus tendon/ligament formation, with additional enhancer dependence confined to tendons/ligaments.

15 November 2023 in bioRxiv
Verified
Preprint
Open access
PDF file
SYShinsei Yambe
Shinsei Yambe
YYYuki Yoshimoto
Yuki Yoshimoto
KIKazutaka Ikeda
Kazutaka Ikeda
KMKoichiro Maki
Koichiro Maki
ATAki Takimoto
Aki Takimoto
CSChisa Shukunami
Chisa Shukunami
Fibrocartilaginous entheses consist of four graded tissue layers including tendon, the unmineralized and mineralized fibrocartilage, and subchondral bone with varying degrees of stiffness. Here we examined the functional role of sclerostin that is expressed in mature mineralized fibrochondrocytes. Following rapid mineralization of the unmineralized fibrocartilage and parallel replacement of epiphyseal hyaline cartilage by bone, the unmineralized fibrocartilage re-expanded after a decline in alkaline phosphatase activity at the mineralization front. Sclerostin was co-expressed with osteocalcin in the bottom of the mineralized fibrocartilage adjacent to subchondral bone. In Scx deficient mice with less mechanical loading due to defects of the Achilles tendon, the number of sclerostin + fibrochondrocytes was significantly reduced in the defective enthesis where chondrocyte maturation was markedly impaired in both fibrocartilage and hyaline cartilage. Loss of the Sost gene, coding for sclerostin, caused increased mineral density in the mineralized zones of the fibrocartilaginous enthesis. Atomic force microscopy analysis revealed the higher stiffness of fibrocartilage. These lines of evidence suggest that sclerostin in mature mineralized fibrochondrocytes acts as a modulator for mechanical tissue integrity of the fibrocartilaginous enthesis.